AFP and hepatocellular carcinoma: As such, the GAAD (gender [biological sex], age, α-fetoprotein [AFP], protein induced by vitamin K absence or antagonist-II [PIVKA-II]) algorithm was developed to assess the utility of AFP-L3 for distinguishing early-stage HCC from benign chronic liver disease36.